FDA approves biosimilar to Remicade for arthritis, IBS

Stephen FellerBETHESDA, Md., April 6 (UPI) -- Inflectra, a drug similar to Remicade, but cheaper, is expected to hit the market in 2016, helping patients with arthritis, IBS and other chronic conditions.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Stephen FellerBETHESDA [+]    April 6 [+]    UPI [+]    Inflectra [+]    Remicade [+]    IBS [+]   

More #news: